Basics Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases. IPO Date: June 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $19.3B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.85% Avg Daily Range (30 D): $1.47 | 1.91% Avg Daily Range (90 D): $1.52 | 2.02% Institutional Daily Volume Avg Daily Volume: .78M Avg Daily Volume (30 D): 3.05M Avg Daily Volume (90 D): 2.25M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 8,303 Avg Inst. Trade: $3.04M Avg Inst. Trade (30 D): $7.42M Avg Inst. Trade (90 D): $8.25M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.64M Avg Closing Trade (30 D): $30.46M Avg Closing Trade (90 D): $23.93M Avg Closing Volume: 158.41K     News Jun 20, 2025 @ 5:37 PM Russell Rebalance: 3 Stocks Ready to Move Higher Source: Marketbeat.Com Jun 11, 2025 @ 5:32 PM Insmed's Pulmonary Hypertension Drug Data Exceeded... Source: Vandana Singh May 23, 2025 @ 8:49 AM 8MM Bronchiectasis Market Opportunity Assessment a... Source: Researchandmarkets.Com Jan 21, 2025 @ 6:00 PM Bronchiectasis Market to Show Positive Growth at a... Source: Delveinsight Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-5.93 $-1.42 $-1.3 Diluted EPS $-5.93 $-1.42 $-1.3 Revenue $ 381.03M $ 92.82M $ 104.44M Gross Profit $ 291.47M $ 71.55M $ 78.29M Net Income / Loss $ -1013.26M $ -256.58M $ -235.55M Operating Income / Loss $ -980.89M $ -248.14M $ -230.41M Cost of Revenue $ 89.56M $ 21.28M $ 26.15M Net Cash Flow $ -192.48M $ -151.78M $ 93.58M PE Ratio     Splits Mar 03, 2011:   1:10 Jul 31, 2000:   1:4